These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1207 related items for PubMed ID: 23340525
21. An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors. Xie H, Li Y, Yu F, Xie X, Qiu K, Fu J. Int J Mol Sci; 2015 Nov 16; 16(11):27350-61. PubMed ID: 26580609 [Abstract] [Full Text] [Related]
22. Design, virtual screening, molecular docking and molecular dynamics studies of novel urushiol derivatives as potential HDAC2 selective inhibitors. Zhou H, Wang C, Ye J, Chen H, Tao R. Gene; 2017 Dec 30; 637():63-71. PubMed ID: 28939339 [Abstract] [Full Text] [Related]
23. Importance of protein flexibility on molecular recognition: modeling binding mechanisms of aminopyrazine inhibitors to Nek2. Tang X, Wang Z, Lei T, Zhou W, Chang S, Li D. Phys Chem Chem Phys; 2018 Feb 21; 20(8):5591-5605. PubMed ID: 29270587 [Abstract] [Full Text] [Related]
24. Importance of protein flexibility in ranking inhibitor affinities: modeling the binding mechanisms of piperidine carboxamides as Type I1/2 ALK inhibitors. Kong X, Pan P, Li D, Tian S, Li Y, Hou T. Phys Chem Chem Phys; 2015 Feb 28; 17(8):6098-113. PubMed ID: 25644934 [Abstract] [Full Text] [Related]
25. Binding mechanism of CDK5 with roscovitine derivatives based on molecular dynamics simulations and MM/PBSA methods. Dong K, Wang X, Yang X, Zhu X. J Mol Graph Model; 2016 Jul 28; 68():57-67. PubMed ID: 27371933 [Abstract] [Full Text] [Related]
26. Molecular modeling study of CP-690550 derivatives as JAK3 kinase inhibitors through combined 3D-QSAR, molecular docking, and dynamics simulation techniques. Wang JL, Cheng LP, Wang TC, Deng W, Wu FH. J Mol Graph Model; 2017 Mar 28; 72():178-186. PubMed ID: 28107751 [Abstract] [Full Text] [Related]
27. Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation. Du J, Sun H, Xi L, Li J, Yang Y, Liu H, Yao X. J Comput Chem; 2011 Oct 28; 32(13):2800-9. PubMed ID: 21717478 [Abstract] [Full Text] [Related]
28. Molecular dynamics simulation, free energy calculation and structure-based 3D-QSAR studies of B-RAF kinase inhibitors. Yang Y, Qin J, Liu H, Yao X. J Chem Inf Model; 2011 Mar 28; 51(3):680-92. PubMed ID: 21338122 [Abstract] [Full Text] [Related]
29. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease. Iqbal S, Anantha Krishnan D, Gunasekaran K. J Biomol Struct Dyn; 2018 Nov 28; 36(15):4029-4044. PubMed ID: 29182053 [Abstract] [Full Text] [Related]
30. Discovery of (S)-6-methoxy-chroman-3-carboxylic acid (4-pyridin-4-yl-phenyl)-amide as potent and isoform selective ROCK2 inhibitors. Pan J, Yin Y, Zhao L, Feng Y. Bioorg Med Chem; 2019 Apr 01; 27(7):1382-1390. PubMed ID: 30819619 [Abstract] [Full Text] [Related]
31. Importance of protein flexibility in molecular recognition: a case study on Type-I1/2 inhibitors of ALK. Kong X, Sun H, Pan P, Zhu F, Chang S, Xu L, Li Y, Hou T. Phys Chem Chem Phys; 2018 Feb 14; 20(7):4851-4863. PubMed ID: 29383359 [Abstract] [Full Text] [Related]
32. Computational determination of binding structures and free energies of glucose 6-phosphate dehydrogenase with novel steroid inhibitors. Zhao ZB, Liu Y, Yao Y. J Mol Graph Model; 2014 Jun 14; 51():168-72. PubMed ID: 24929815 [Abstract] [Full Text] [Related]
33. Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors. Tripathi SK, Muttineni R, Singh SK. J Theor Biol; 2013 Oct 07; 334():87-100. PubMed ID: 23727278 [Abstract] [Full Text] [Related]
34. Novel urushiol derivatives as HDAC8 inhibitors: rational design, virtual screening, molecular docking and molecular dynamics studies. Zhou H, Wang C, Deng T, Tao R, Li W. J Biomol Struct Dyn; 2018 Jun 07; 36(8):1966-1978. PubMed ID: 28632421 [Abstract] [Full Text] [Related]
35. Probing the binding mechanism of mercaptoguanine derivatives as inhibitors of HPPK by docking and molecular dynamics simulations. Marimuthu P, Singaravelu K, Namasivayam V. J Biomol Struct Dyn; 2017 Dec 07; 35(16):3507-3521. PubMed ID: 27844507 [Abstract] [Full Text] [Related]
36. Insight into the binding mode between N-methyl pyrimidones and prototype foamy virus integrase-DNA complex by QM-polarized ligand docking and molecular dynamics simulations. Reddy KK, Singh SK. Curr Top Med Chem; 2015 Dec 07; 15(1):43-9. PubMed ID: 25579571 [Abstract] [Full Text] [Related]
37. Molecular modeling and molecular dynamics simulation studies on pyrrolopyrimidine-based α-helix mimetic as dual inhibitors of MDM2 and MDMX. Lu SY, Jiang YJ, Zou JW, Wu TX. J Mol Graph Model; 2011 Sep 07; 30():167-78. PubMed ID: 21820342 [Abstract] [Full Text] [Related]
38. Investigating molecular dynamics-guided lead optimization of EGFR inhibitors. Lavecchia MJ, Puig de la Bellacasa R, Borrell JI, Cavasotto CN. Bioorg Med Chem; 2016 Feb 15; 24(4):768-78. PubMed ID: 26810832 [Abstract] [Full Text] [Related]
39. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors. Venugopal PP, Das BK, Soorya E, Chakraborty D. Proteins; 2020 Feb 15; 88(2):327-344. PubMed ID: 31443129 [Abstract] [Full Text] [Related]
40. Insight into mechanism of small molecule inhibitors of the MDM2-p53 interaction: molecular dynamics simulation and free energy analysis. Chen J, Wang J, Xu B, Zhu W, Li G. J Mol Graph Model; 2011 Sep 15; 30():46-53. PubMed ID: 21764342 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]